ASSERTIO THERAPEUTICS, INC. Revenue, Net (Deprecated 2018-01-31)
ASSERTIO THERAPEUTICS, INC. reported Revenue, Net (Deprecated 2018-01-31) of $9.13 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2013-05-09
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $9.13M, a 332.86% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $12.49M, a 2358.46% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $9.68M, a 5.20% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $3.20M, a 80.18% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2012 was $27.48M, a 33.26% decline from fiscal 2011.
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2011 was $41.18M, a 9.77% decline from fiscal 2010.
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2010 was $45.64M, a 30.04% increase from fiscal 2009.
- ASSERTIO THERAPEUTICS, INC. revenue, net (deprecated 2018-01-31) for fiscal 2009 was $35.09M.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $9.13M 10-Q · filed 2013-05-09 | $21.62M derived: sum of 2 quarters · filed 2013-05-09 | $31.30M derived: sum of 3 quarters · filed 2013-05-09 | $34.50M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-12-31 | $12.49M 10-K · filed 2013-02-22 | $22.17M derived: sum of 2 quarters · filed 2013-02-22 | $25.37M derived: sum of 3 quarters · filed 2013-02-22 | $27.48M 10-K · filed 2013-02-22 |
| 2012-09-30 | $9.68M 10-K · filed 2013-02-22 | $12.88M derived: sum of 2 quarters · filed 2013-02-22 | $14.99M 10-Q · filed 2012-11-05 | $15.50M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-06-30 | $3.20M 10-K · filed 2013-02-22 | $5.31M 10-Q/A · filed 2012-08-13 | $5.82M derived: sum of 3 quarters · filed 2013-05-09 | $15.02M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-03-31 | $2.11M 10-Q · filed 2013-05-09 | $2.62M derived: sum of 2 quarters · filed 2013-05-09 | $11.82M derived: sum of 3 quarters · filed 2013-05-09 | $27.98M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $508.00K 10-K · filed 2013-02-22 | $9.71M derived: sum of 2 quarters · filed 2013-02-22 | $25.87M derived: sum of 3 quarters · filed 2013-02-22 | $41.18M 10-K · filed 2013-02-22 |
| 2011-09-30 | $9.21M 10-K · filed 2013-02-22 | $25.36M derived: sum of 2 quarters · filed 2013-02-22 | $40.67M 10-Q · filed 2012-11-05 | $52.22M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | $16.15M 10-K · filed 2013-02-22 | $31.46M 10-Q/A · filed 2012-08-13 | $43.02M derived: sum of 3 quarters · filed 2013-02-22 | $52.84M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | $15.31M 10-K · filed 2013-02-22 | $26.86M derived: sum of 2 quarters · filed 2013-02-22 | $36.69M derived: sum of 3 quarters · filed 2013-02-22 | $48.35M derived: sum of 4 quarters · filed 2013-02-22 |
| 2010-12-31 | $11.55M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $21.38M derived: sum of 2 quarters · filed 2013-02-22 | $33.04M derived: sum of 3 quarters · filed 2013-02-22 | $45.64M 10-K · filed 2013-02-22 |
| 2010-09-30 | $9.83M 10-Q · filed 2011-11-07 | $21.49M derived: sum of 2 quarters · filed 2011-11-07 | $34.09M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $11.66M 10-Q · filed 2011-08-02 | $24.26M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | $35.09M 10-K · filed 2012-03-08 |